• Ownership

Helen M. Thackray - Insider Trading & Ownership

Entity
Individual
Location
C/O Glycomimetics, Inc., 401 Professional Drive, Suite 250, Gaithersburg, MD
Summary
The estimated net worth of Helen M. Thackray is at least $2.93M dollars as of April 2, 2025. Helen M. Thackray is the Chief R&D Officer of BIOCRYST PHARMACEUTICALS INC and owns shares of BIOCRYST PHARMACEUTICALS INC (BCRX) stock worth about $2.83M. Helen M. Thackray is the Director of ImmunoGen, Inc. and owns shares of ImmunoGen, Inc. stock worth about $102K.
All Insider Reports
All Insider Reports

Ownership of Helen M. Thackray

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BCRX BIOCRYST PHARMACEUTICALS INC Chief R&D Officer $2.83M +$176K +6.62% Mar 31, 2025
IMGN ImmunoGen, Inc. Director $102K Feb 12, 2024

Insider Transactions Reported by Helen M. Thackray:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.